Search research articles
Contact Us
Filters
Showing results (91-100 of 268) with videos related to
Page
of 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2018
IL-1β enables CNS access to CCR2<sup>hi</sup> monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells
Alexandre Paré, Benoit Mailhot, Sébastien A Lévesque, et al.
Nature Aging
|
April 28, 2023
Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging
Yifei Dong, Rajiv W Jain, Brian M Lozinski, et al.
Clinical & Translational Immunology
|
March 17, 2021
The IL-27/IL-27R axis is altered in CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes from multiple sclerosis patients
Marie-Laure Clénet, Cyril Laurent, Florent Lemaitre, et al.
Journal of Neuroinflammation
|
November 2, 2024
Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis
Sienna S Drake, Aliyah Zaman, Christine Gianfelice, et al.
Neurobiology of Disease
|
February 26, 2017
Laquinimod enhances central nervous system barrier functions
Fred Lühder, Hania Kebir, Francesca Odoardi, et al.
Nature Communications
|
February 28, 2018
EGFL7 reduces CNS inflammation in mouse
Catherine Larochelle, Timo Uphaus, Bieke Broux, et al.
International Journal of Molecular Sciences
|
December 11, 2022
3-Dimensional Immunostaining and Automated Deep-Learning Based Analysis of Nerve Degeneration
Sienna S Drake, Marc Charabati, Tristan Simas, et al.
Annals of Neurology
|
April 15, 2015
Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation
Catherine Larochelle, Marc-André Lécuyer, Jorge Ivan Alvarez, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations
Mark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 29, 2025
Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models
Cenxiao Li, Marlene T Morch, Rianne Gorter, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 268) with videos related to
Sort By:
Page
of 27
Proceedings of the National Academy of Sciences of the United States of America
|
January 24, 2018
IL-1β enables CNS access to CCR2<sup>hi</sup> monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells
Alexandre Paré, Benoit Mailhot, Sébastien A Lévesque, et al.
Nature Aging
|
April 28, 2023
Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging
Yifei Dong, Rajiv W Jain, Brian M Lozinski, et al.
Clinical & Translational Immunology
|
March 17, 2021
The IL-27/IL-27R axis is altered in CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes from multiple sclerosis patients
Marie-Laure Clénet, Cyril Laurent, Florent Lemaitre, et al.
Journal of Neuroinflammation
|
November 2, 2024
Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis
Sienna S Drake, Aliyah Zaman, Christine Gianfelice, et al.
Neurobiology of Disease
|
February 26, 2017
Laquinimod enhances central nervous system barrier functions
Fred Lühder, Hania Kebir, Francesca Odoardi, et al.
Nature Communications
|
February 28, 2018
EGFL7 reduces CNS inflammation in mouse
Catherine Larochelle, Timo Uphaus, Bieke Broux, et al.
International Journal of Molecular Sciences
|
December 11, 2022
3-Dimensional Immunostaining and Automated Deep-Learning Based Analysis of Nerve Degeneration
Sienna S Drake, Marc Charabati, Tristan Simas, et al.
Annals of Neurology
|
April 15, 2015
Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation
Catherine Larochelle, Marc-André Lécuyer, Jorge Ivan Alvarez, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations
Mark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
May 29, 2025
Bruton Tyrosine Kinase in Lesions of Multiple Sclerosis and 3 of Its Models
Cenxiao Li, Marlene T Morch, Rianne Gorter, et al.
Page
of 27